Pan-Mass Challenge raises $33.5 million over weekend bike ride for Dana-Farber

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A total of 6,000 cyclists participated in THE PAN-MASS CHALLENGE, a two-day bike fundraiser involving 12 routes and 46 Massachusetts towns, raising over $33.5 million.

Joined by Governor Charlie Baker and Boston Mayor Marty Walsh, cyclists from 40 states and five countries rode to raise money for adult and pediatric cancer research at Dana-Farber Cancer Institute through the Jimmy Fund. The goal was to bring the PMC’s 35-year fundraising total to a half billion dollars raised since the organization’s inception in 1980.

“Each year, we are astonished by the unparalleled support that Dana-Farber receives from the PMC, and this year is no different,” said Edward Benz Jr., president and CEO of Dana-Farber. “We are deeply grateful for the PMC’s partnership and unwavering commitment.”

One-day routes include riding from Wellesley or Sturbridge to Bourne, Wellesley to Patriot Place and Bourne to Provincetown. Two-day routes include Wellesley or Sturbridge to Provincetown, and Wellesley or Sturbridge to Bourne and back. The average cyclist trains for three months, solicits 40 sponsors, and raises more than $6,500, according to PMC.

The PMC is presented by the Red Sox Foundation and the New Balance Foundation. Another 200 companies support the event by providing more than $4 million in goods and services each year. During PMC weekend and throughout the year, more than 4,000 volunteers donate their time to support the organization.

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login